Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin

被引:233
作者
Agrawal, A
Lingappa, J
Leppla, SH
Agrawal, S
Jabbar, A
Quinn, C
Pulendran, B
机构
[1] Emory Vaccine Res Ctr, Atlanta, GA 30329 USA
[2] CDCP, Meningitis & Special Pathogens Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA
[3] NIAID, Microbial Pathogenesis Sect, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
Dendritic cells;
D O I
10.1038/nature01794
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 [理学]; 0710 [生物学]; 09 [农学];
摘要
Anthrax poses a clear and present danger as an agent of biological terrorism(1-3). Infection with Bacillus anthracis, the causative agent of anthrax, if untreated can result in rampant bacteraemia, multisystem dysfunction and death(4-8). Anthrax lethal toxin (LT) is a critical virulence factor of B. anthracis, which occurs as a complex of protective antigen and lethal factor. Here we demonstrate that LT severely impairs the function of dendritic cells-which are pivotal to the establishment of immunity against pathogens- and host immune responses by disrupting the mitogen-activated protein (MAP) kinase intracellular signalling network. Dendritic cells exposed to LT and then stimulated with lipopolysaccharide do not upregulate co-stimulatory molecules, secrete greatly diminished amounts of proinflammatory cytokines, and do not effectively stimulate antigen-specific T cells in vivo. Furthermore, injections of LT induce a profound impairment of antigen-specific T- and B-cell immunity. These data suggest a role for LT in suppressing host immunity during B. anthracis infections, and represent an immune evasion strategy, where a microbe targets MAP kinases in dendritic cells to disarm the immune response.
引用
收藏
页码:329 / 334
页数:6
相关论文
共 30 条
[1]
Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[2]
Identification of the cellular receptor for anthrax toxin [J].
Bradley, KA ;
Mogridge, J ;
Mourez, M ;
Collier, RJ ;
Young, JAT .
NATURE, 2001, 414 (6860) :225-229
[3]
Toxins of Bacillus anthracis [J].
Brossier, F ;
Mock, M .
TOXICON, 2001, 39 (11) :1747-1755
[4]
Anthrax [J].
Dixon, TC ;
Meselson, M ;
Guillemin, J ;
Hanna, PC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (11) :815-826
[5]
MAP kinases in the immune response [J].
Dong, C ;
Davis, RJ ;
Flavell, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :55-72
[6]
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor [J].
Duesbery, NS ;
Webb, CP ;
Leppla, SH ;
Gordon, VM ;
Klimpel, KR ;
Copeland, TD ;
Ahn, NG ;
Oskarsson, MK ;
Fukasawa, K ;
Paull, KD ;
Vande Woude, GF .
SCIENCE, 1998, 280 (5364) :734-737
[7]
ON THE ROLE OF MACROPHAGES IN ANTHRAX [J].
HANNA, PC ;
ACOSTA, D ;
COLLIER, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) :10198-10201
[8]
Understanding Bacillus anthracis pathogenesis [J].
Hanna, PC ;
Ireland, JAW .
TRENDS IN MICROBIOLOGY, 1999, 7 (05) :180-182
[9]
THE MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED ANTIGEN RECEPTOR ON T-CELLS .1. ISOLATION WITH A MONOCLONAL-ANTIBODY [J].
HASKINS, K ;
KUBO, R ;
WHITE, J ;
PIGEON, M ;
KAPPLER, J ;
MARRACK, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 157 (04) :1149-1169
[10]
In vivo detection of dendritic cell antigen presentation to CD4(+) T cells [J].
Ingulli, E ;
Mondino, A ;
Khoruts, A ;
Jenkins, MK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (12) :2133-2141